Generali : Towards the breakout of a major resistance level
| Entry price | Target | Stop-loss | Potential |
|---|
|
€34.65 |
€37.1 |
€33 |
+7.07% |
|---|
Generali shares are reaching an interesting resistance zone. The current technical chart pattern suggests that a breach of this level could lead to new upside potential.
Summary● On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
● The company has a good ESG score relative to its sector, according to MSCI.
Strengths● The company's profit outlook over the next few years is a strong asset.
● With a P/E ratio at 12.35 for the current year and 11.05 for next year, earnings multiples are highly attractive compared with competitors.
● The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
● The company is one of the best yield companies with high dividend expectations.
● The group usually releases upbeat results with huge surprise rates.
Weaknesses● Revenue estimates are regularly revised downwards for the current and coming years.
● Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
● The overall consensus opinion of analysts has deteriorated sharply over the past four months.
© MarketScreener.com -
2025
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener Saudi Arabia. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.